Preclinical and clinical studies of innovative nanoformulations of anticancer drugs
Nano-sized, polysaccharide delivery system of 5-fluorouracil in the target oncological therapy
Development of new cancer therapies based on selective antitumor immunomodulators
Support for patent protection of PCT application for technology and the use of polysaccharide carriers dedicated to oncological treatment
Partnering with NanoVelos
Our chemists are looking forward to conjugating your drug with dextran nanoparticles and making it ready for preclinical trials. Please contact us to start collaborating!